| Pharmaceutical active ingredients: |
| Diphenoxylate HydrochlorideNeomycin Sulfate |
| Available forms, composition and doses of Diarsed Neomycine: |
| N / A |
| Diarsed Neomycine medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07AA51 - Neomycin, combinationsA07DA01 - Diphenoxylate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Retardin | Diphenoxylate Hydrochloride | Janssen |
| Setmotil | Diphenoxylate Hydrochloride | Strand, Malaysia; Pharmaniaga |
| Tropergen | Diphenoxylate Hydrochloride | Goldshield Pharmaceuticals |
| Colestase | Diphenoxylate Hydrochloride; Furazolidone | Sanofi-Aventis |
| Saleton | Diphenoxylate Hydrochloride; Furazolidone; Neomycin Sulfate | Roche |
| Denax | Diphenylguanidine | Unidentified Pharmaceutical Company |
| Melaniline | Diphenylguanidine | Unidentified Pharmaceutical Company |
| Vulcacid D | Diphenylguanidine | Unidentified Pharmaceutical Company |
| Vulkazit | Diphenylguanidine | Unidentified Pharmaceutical Company |
| Belfene | Diphenylpyraline | Unidentified Pharmaceutical Company |